Second Wave Fear :
Many countries across the world are witnessing a resurgence in their daily coronavirus (Covid-19) cases and deaths.
Cities such as New York in the US, Turin in Italy, and London in the UK have been placed under stringent lockdowns due to the possibility of a second wave of the outbreak fear.
India going to the lowest covid-19 cases in their days.
Apart from the imposition of lockdowns, governments have also increased testing and surveillance to detect those infected at the earliest which in turn would help curb the spread of the disease in their areas and villages.
please follow the government rules and the curfew But there seems no other way to bring a complete pause to the pandemic other than a vaccine - which is safe, affordable, and effective.
Speaking to news agency AFP, a World Health Organisation (WHO) expert said that public distrust risked rendering even the most effective treatments useless against the Covid-19 crisis.
RESEARCH INSTITUTIONS :
Few weeks or next month are releasing the vaccine following research institutions(companies)
After Pfizer, another US drugmaker, Moderna Inc.
With fewer possibilities of a sharp drop in the world caseload which has already infected over 53 million peoples and killed 1,309,408
1. Operation Warp Speed chief adviser Moncef Slaoui during a press briefing at the White House said that the United States(USA) hopes to immunize 20 million citizens in December and a minimum of 25 million each month next year. Slaoui added that he hopes two vaccines in the final phase of trials developed by Pfizer and Moderna would soon be approved for emergency use next month.
Steal of data :
*On Friday, software giant Microsoft in its blog post said that hackers from North Korea and Russia were trying to steal valuable data from companies engaged in the research and development of coronavirus vaccines.
*Microsoft added that the majority of these attacks were unsuccessful 3. The first phase trials of another vaccine of Biological E, a Hyderabad-based biopharmaceutical, Patna.
People between the ages of 18-55 can volunteer to receive the shot of this covid-19 vaccine.
COVAX - formed by the WHO and vaccine alliance Gavi to provide equitable access to the coronavirus vaccine - has exceeded an interim target of increasing more than $2 billion(2000 cr) to buy and distribute vaccines for poorer countries.
India :
Pune serum research institution production covid-19 vaccine
Serum Institute of India (SII) and Indian Council of Medical Research (ICMR)announce the completion of enrolment of phase 3 clinical trials for COVISHIELD in India. ICMR and SII have further collaborated for clinical development COVOVAX (Novavax)
South Korea :
GL Rapha will produce 150 million(15 cr) doses of Russia’s Sputnik V coronavirus vaccine per year. The Russian Direct Investment Fund (RDIF) on Friday said that the South Korean firm is expected to begin production next month.
****************************************
Comments
Post a Comment